The management of bowel obstruction in advanced gynaecological malignancy
The management of bowel obstruction in advanced gynaecological malignancy
This chapter focuses on malignant bowel obstruction (MBO), a common complication in women diagnosed with ovarian cancer, colorectal cancer, and other gynaecological malignancies. MBO generally afflicts 25–42 per cent of patients with advanced ovarian cancer, but rarely occurs in patients with endometrial cancer. MBO develops by the existence of mechanical obstruction from an extrinsic occlusion of the bowel lumen, intraluminal occlusion of the lumen, luminal obstruction due to tumour growth in the bowel wall, and adynamic ileus. Bowel obstruction can also be caused by other non-malignant factors such as adhesion, post-irridation bowel damage, hernias, and inflammatory bowel disease. Management of MBO includes pain management, pharmacological management, and non-pharmacological management. In patients with MBO, pharmacological treatment is generally successful. Only patients who are strictly considered as appropriate candidates for surgery and parenteral nutrition are given such treatments.
Keywords: malignant bowel obstruction, MBO, bowel obstruction, obstruction, bowel lumen, mechanical obstruction, intraluminal occlusion, luminal obstruction, adynamic ileus, bowel damage
Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .
